Vinpai SAS (ALVIN) - Total Liabilities
Based on the latest financial reports, Vinpai SAS (ALVIN) has total liabilities worth €10.77 Million EUR (≈ $12.59 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Vinpai SAS equity growth rate to track the company's year-over-year net asset growth rate.
Vinpai SAS - Total Liabilities Trend (2020–2024)
This chart illustrates how Vinpai SAS's total liabilities have evolved over time, based on quarterly financial data.
Vinpai SAS Competitors by Total Liabilities
The table below lists competitors of Vinpai SAS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Barrel Co. Ltd
KQ:267790
|
Korea | ₩32.33 Billion |
|
Citius Pharmaceuticals Inc
NASDAQ:CTXR
|
USA | $63.46 Million |
|
OHEIM INT Co.Ltd
KQ:309930
|
Korea | ₩35.43 Billion |
|
iZafe Group AB Series B
ST:IZAFE-B
|
Sweden | Skr26.10 Million |
|
Medifron DBT Co. Ltd
KQ:065650
|
Korea | ₩86.61 Billion |
|
Cyngn Inc
NASDAQ:CYN
|
USA | $11.30 Million |
|
Korean Air Lines Co Ltd
KO:003495
|
Korea | ₩42.04 Trillion |
|
Deltamac Taiwan Co Ltd
TWO:6144
|
Taiwan | NT$53.16 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Vinpai SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALVIN market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -23.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vinpai SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vinpai SAS (2020–2024)
The table below shows the annual total liabilities of Vinpai SAS from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €10.77 Million ≈ $12.59 Million |
+48.66% |
| 2023-12-31 | €7.25 Million ≈ $8.47 Million |
-8.57% |
| 2022-12-31 | €7.92 Million ≈ $9.26 Million |
+3.51% |
| 2021-12-31 | €7.66 Million ≈ $8.95 Million |
+30.48% |
| 2020-12-31 | €5.87 Million ≈ $6.86 Million |
-- |
About Vinpai SAS
Vinpai SAS designs, manufactures, and markets a range of functional ingredients based on algae, plants, minerals, and fibers. Its functional ingredients are used as natural alternatives to chemical additives in the food, cosmetics, nutritional supplementation and medical device industries. The company offers plant-based flavors, cheeses, dairy products, dressing sauces and French fries, and cakes… Read more